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Summary Volatile sulfur compounds (VSCs), mainly composed of hydrogen sulfide (H2S) and
methyl mercaptan (CH3SH), cause halitosis. VSCs increase the permeability of a model for gingival
crevicular epithelia, causing an increase in the penetration of lipopolysaccharide, as well as
prostaglandin, into the tissue. VSCs inhibit the proliferation of human gingival fibroblasts (HGF),
human gingival epithelial cells (HGEC) and osteoblasts. H2S also causes apoptosis in HGF and HGEC.
Furthermore,VSCs increasecollagendegradationandreducecollagen synthesis inHGFand suppress
wound healing, especially the formation of basal membrane and Type IV collagen synthesis.
Moreover, VSCs stimulate interleukin-1 production, resulting in an increase in prostaglandin E
and matrix metalloproteinase 1. Thus, VSCs may induce the initial damage to the epithelial barrier
in the progression of periodontal disease. VSCs, especially H2S, strongly inhibit cytochrome c
oxidase, which is a key enzyme for oxidative phosphorylation in the respiratory chain. Therefore,
high concentration of VSCs causes lethal toxicities as well as cyanide. On the other hand, very low
concentration of H2S at lower concentration in periodontal pocket causes genomic DNA damages in
both HGF and HGEC. It has been suggested that VSCs may be one of the contributing factors for
carcinogenesis because of increasing oxidative stress, and as the Ras/mitogen activated protein
kinase signaling pathway, which is constitutively activated in many types of cancer, is enhanced.
# 2008 Japanese Association for Dental Science. Published by Elsevier Ireland. All rights reserved.Contents
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An oversupply of dentists has become a big topic in Japanese
dental society, where only 16% of the population receive
regular dental examinations [1], while 66% of the population
in USA visit dentists at least once a year [2]. The shortage of
dental practitioners in the USA started several years ago,
although the number of practitioners per capita is similar to
the Japanese number [3]. People’s attitudes and behaviors
towards their own oral health are transformed by oral health
promotion, and dentistry in developed countries has thus
achieved social recognition. Dental research contributes
greatly to oral health promotion, but a particular area of
research that is generally disregarded by dental researchers
— the very one that, ironically, rouses much public interest in
dentistry — is halitosis, which can provide excellent educa-
tional material to encourage people to visit dentists regularly.
Oral malodor is caused by volatile sulfur compounds (VSCs)
such as hydrogen sulfide (H2S) and methyl mercaptan
(CH3SH). Yaegaki and Sanada [4] have proved that H2S is a
main cause of physiological halitosis, while CH3SH is respon-
sible for oral pathologic halitosis caused by periodontal
conditions. The guidelines of halitosis treatment have been
ascertained by Miyazaki et al. [5], and halitosis clinics have
been well established for the past decade [6]. Consequently,
clinicians’ interest in halitosis has increased; however, it is
not yet generally known that VSCs are toxic to human tissues,
especially periodontal tissue, as demonstrated by Tonzetich
and co-workers [7].
Periodontitis is initiated by the invasion of periodontal
pathogens and/or the penetration of microbial products into
the gingival tissues, accompanied by a series of inflammatory
reactions by host factors. The host factors of periodontitis
are clearly identified, but the etiology of periodontitis has
not yet been explicitly illustrated, especially at its initial
stage [7]. It has been recently elucidated that VSCs reduce
the effectiveness of the gingival epithelial tissues that
normally play a key role as a barrier against penetration
and invasion by detrimental compounds and microorganisms
[8—25].
Some epidemiological and clinical studies have demon-
strated that H2S is related to general conditions. Specifically,
a high concentration of H2S in the colon has been reported as
being one of the most likely causes of colon cancer [26]. We
have recently found that H2S existing in periodontal pockets
inhibits a superoxide scavenger that prevents oxidative
damage of the tissues, and thus it causes genomic DNA
damage [27]. In this review, the toxic effects of VSCs on
human tissues are described.
2. Toxicity of VSCs in general conditions
As the toxicity of VSCs, especially H2S, is similar to that of
hydrogen cyanide, VSCs’ toxic effects on human tissue are
well documented. H2S is recognized to be a potent inhibitor
of cytochrome c oxidase (COX), which is a key enzyme foroxidative phosphorylation in the respiratory chain in the
mitochondria to produce adenosine triphosphate (ATP)
[28]. COX inhibition by H2S has been observed not only in
vivo for some tissues, but also in purified COX from mito-
chondria [28,29]. The key mechanism by which H2S inhibits
COX is in its binding to the heme iron of the enzyme, thus
completely inhibiting the aerobic metabolism producing ATP
[29]. Exposure to H2S can also occur in some occupational
accidents or by means of environmental pollution. Concen-
trations over 500 ppm result in immediate death caused by
cardiac arrhythmia and respiratory paralysis [30].
Healthy human subjects show blood sulfide ranging from
10 to 100 mmol/l, equivalent to 0.2—1.8 ppm in blood [31],
although the free sulfide in the ultrafiltered serum was not
detected [32]. As 60 ppb—0.6 ppm of sulfide were demon-
strated in the culture medium utilized for experiments that
examined the adverse effects of VSCs on human cell cultures,
these studies, which were discussed in this paper, could
simulate of the conditions of human tissues [8—25]. Total
VSCs or H2S concentration in mouth air from healthy subjects
is reported as a maximum of 2 ppm or 1 ppm, while several
times this concentration is found in periodontal patients
[4,33,34]. In a group of asthmatics exposed to 2 ppm hydro-
gen sulfide for 30 min, airway resistance increased, implying
bronchial obstruction [35]. Furthermore, a longitudinal study
demonstrated the experience of general symptoms in sub-
jects exposed to ambient-air malodorous sulfur compounds
(reference: daily mean H2S concentration is<7 ppb; medium
exposure: 7—21 ppb H2S; high exposure: >21 ppb H2S). The
incidence of eye, respiratory and central nervous symptoms
was significantly higher on days of medium and high exposure
compared with the reference [36]. Eye injury was also docu-
mented; acute exposure to 25 ppb H2S is the lowest concen-
tration to irritate the eyes; with chronic exposure, serious
eye effects are possible [37].
These results imply that much lower levels of H2S than the
concentration in mouth air cause exposure-related adverse
effects. Therefore, VSCs in mouth air are very likely to cause
unpleasant outcomes, but no clinical study has reported the
relationship between inhaled VSCs in mouth air and these
conditions. On the other hand, the mass absorption of VSCs
was found fromperiodontal pocket into oral tissues [7—9], and
it is expected that absorbed VSCs will be carried by blood as
well as VSCs produced in the colon. However, VSCs absorbed by
the colon carried into the liver where the toxic compounds are
detoxified, whereas VSCs absorbed by oral tissues are directly
carried to the other organs including heart or brain. Further
studies for the toxicities of VSCs produced in the oral cavity
would be required.
3. Carcinogenicity of VSCs
H2S causes genomic DNA damage in human tissues [27]. DNA
damage in HGF and human gingival epithelial cells (HGEC)
exposed to 100 ng/ml H2S were detected by single-cell
gel electrophoresis assay (SCGE) (CometAssyTM, Trevigen,
Figure 2 Possible mechanisms of carcinogenicity of H2S
[26,45—50].
102 K. YaegakiGaithersburg, MD, USA). The basis of SCGE is the migration of
DNA in an agarose gel under electrophoretic conditions.
Intact DNA migrates more slowly and remains within the
nucleoid, whereas damaged DNA migrates faster. When
viewed under a microscope, a cell has the appearance of a
comet, with a head (the nuclear region) and a tail containing
DNA fragments. Evaluation of the DNA ‘‘comet’’ tail shape
allows for assessment of DNA damage. Therefore, the DNA
damage caused by H2S was determined by assessing tail
length (=whole length of comet  length of head), %DNA in
the tail (=tail area/(tail area + head area)  100), and tail
moment (=tail length  %DNA in the tail). In HGF, a significant
difference was found between the test groups in tail length
and tail moment ( p < 0.0001, respectively) as well as in DNA
in the tail ( p < 0.05). (Fig. 1). Similar results were also
demonstrated in HGEC (data are not shown). Matias et al.
[38] have shown genotoxicity of H2S in several kinds of cell
lines using SCGE, and have suggested that H2S-induced DNA
damage might be mutagenic or carcinogenic, or play a role in
chromosomal instability formation. Yang and Wong [39] have
indicated that the effects of H2S on cell function have two
aspects, apoptosis and cell-proliferation, indicating its car-
cinogenicity.
In comparison to the sulfur concentration in the period-
ontal pocket, much higher concentration of H2S, over
1000 ppm greater than the lethal dose exists in the colon
[40—42]. Colonic epithelium cope with this toxicity by
methylation and de-methylation [42,43]. The detoxification
activity of H2S in the colonic mucosa is alsomuch higher than
in other tissues, therefore the colonic mucosa protects
itself from severe injuries such as ulcerative colitis [42—
46]. Ulcerative colitis is recognized as a pre-cancerous
condition, and this condition is linked to increased fecal
production of VSCs as potential causative agents [47,48].
Thiols react with sulfhydryl-containing compounds to form
persulfides, and then alter cell metabolism including VSCs
detoxification; consequently a defect in VSCs metabolism
may allow accumulation of VSCs, with resultant tissue dam-
age [42]. Incubation of colonic mucosa with H2S producedFigure 1 Quantitation of DNA strand breaks caused by H2S
incubation [27]. The cells were incubated with either 5% CO2 in
air with H2S (100 ng/ml) or 5% CO2 in air alone for 72 h. DNA
strand breaks were detected using the CometAssayTM. Data were
obtained from six independent experiments, 75 nuclei per
experiment. Asterisk indicates a statistically significant differ-
ence between the test treated with H2S and the control
(p < 0.0001).significant damage including apoptosis, loss of goblet cells,
and superficial ulcerations [49]. H2S concentration in feces
from subjects at high risk of sigmoid colon cancer was
significantly higher than in the control group [41]. Prolifera-
tion of colonic mucous cells was accelerated by H2S, and
controlled by the Ras family that consists of Ha-ras, Ki-ras,
and N-ras genes [50,51]. In fact, activated Ki-ras was fre-
quently found in human colorectal cancers [51]. As Ras
activates mitogen activated protein kinase (MAPK) which
affects its downstream pathways, Ras oncogene is impli-
cated in colorectal carcinogenesis [52]. Possible mechan-
isms have been illustrated for the subcellular explanation of
hydrogen sulfide’s carcinogenicity (Fig. 2) [26,45—50].
Deplancke and Gaskins have found that H2S causes a reduced
redox environment in intestinal cells, which triggers the
Ras/MAPK pathway (Fig. 3) [26]. Similar carcinogenicity in
oral tissues should be investigated in further studies.
Superoxide dismutase (SOD) is a critical enzyme respon-
sible for the elimination of superoxide radicals. Accumula-Figure 3 Hypothesis of carcinogenesis mechanism by high
concentration of H2S through Ras/MAPK pathway, modified from
Deplancke and Gaskins [26]. Dependent on genetic background,
this event may result in hyperproliferation, ulcerative colitis and
colorectal cancer [26]. (Reproduced with the permission of Dr.
Rex H. Gaskins.)
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oxidative stress; if the stress is not corrected in time, it
can lead to the damage of important biomolecules such as
membrane lipids, proteins and DNA. Prolonged accumulation
of free radicals may cause irreversible cellular injury. SOD is
the key enzyme in the first metabolic step of superoxide
elimination. Deficiency in SOD or inhibition of its activity may
cause severe accumulation of O2
 or H2O2 in cells. We
recently found that very low concentrations of H2S, much
lower than those found in human periodontal pockets, inhibit
SOD activity in HGF, as well as Cu, Zn—SOD and Mn—SOD
activities [27]. We also determined that H2S elevates the
level of ROS, which may cause oxidative stress that is asso-
ciated with cancer or aging [27].
4. Effects of VSCs on apoptosis and cell
proliferation
VSCs induce cell death in gingival tissue; a large number of
dead or impaired cells were found in an epithelial model of
gingival crevices after exposure to VSCs [9]. VSCs also delay
wound healing. CH3SH has been found to delay wound healing
in rats; furthermore, in a wound treated with CH3SH in an
epithelial model of gingival crevices, no formation of Type IV
collagen was found [19].
The effects of VSCs on the proliferation of both fibroblasts
and epithelial cells have been studied. It was found that VSCs
adversely affect only certain types of fibroblasts, which may
indicate that there is a selection process for particular
fibroblast cell populations [14]. The proliferation of both
HGF and HGEC was inhibited by VSCs [19,20,53]. We have
recently found that H2S caused apoptosis in HGF (Fig. 4) [27].
Apoptosis in HGEC was also caused by H2S; moreover, H2S
induced cell-cycle arrest via the expression of p21 in HGEC
[53,54]. The upper stream of the signaling pathway involving
Caspase 3 may be activated, because H2S significantly ele-
vates the level of the enzyme [27]. It has also been suggestedFigure 4 Ratio of early apoptosis induced by H2S [27]. The cells
were incubated with either 5% CO2 in air with H2S (100 ng/ml) or
5% CO2 in air alone for the times indicated. Cells were stained
with annexin V and propidium iodide. Apoptotic cells were
detected by flow cytometry. Asterisk indicates a statistically
significant difference between treatment with H2S and the con-
trol ( p < 0.05).that H2S propels the cell toward apoptotic death triggered
initially by stabilization of p53 and that subsequently involves
a cascade of downstream products [55]. In the early stages of
periodontitis, the number of apoptotic cells among period-
ontal ligament fibroblasts increases significantly [56]. Apop-
tosis has also been found in these tissues in human aggressive
or severe periodontitis [57—60]. Periodontal pathogenic
microorganisms play etiological roles in the apoptotic process
of periodontal tissues [58,60]. Lipoprotein of Bacteroids
forsythus also induced apoptosis in HGF and human gingival
keratinocytes [61]. A signaling pathway of apoptosis caused
by lipoprotein was mediated by Toll-like receptor 2 [62]. In
this process, NF-kappa B was partly activated via the PI3 ki-
nase/AKT pathway in HGF after Porphyromonas gingivalis
infection [60]. At the later stages of infection, the anti-
apoptotic genes were largely shut down and the pro-apop-
totic genes were activated [63]. Therefore, apoptosis occur-
ring in periodontal tissues is considered to be one of the
etiologic processes of periodontitis.
To investigate the effect of oral malodorous compounds on
the proliferation of osteoblasts and on a signaling transduc-
tion pathway through the MAPK cascade, normal human
osteoblasts (NHOst) and murine osteoblasts (MC3T3-E1),
were cultured in the presence of H2S. Cell proliferations of
both NHOst and MC3T3-E1were significantly suppressed by
H2S, furthermore, the phosphorylation of ERK1/2 and p38
increased as the H2S concentration increased (data are not
shown).
5. Effects of VSCs on the permeability of the
mucosa
Basal membrane of epithelium is the barrier against the
penetration of tumor cells into subcutaneous tissue. In per-
iodontal tissue, the onset of periodontal disease follows
initial damage to the gingival sulcular epithelial barrier
[7]. VSCs increased permeability in porcine sublingual non-
keratinized mucosa, a model for crevicular epithelia (Fig. 5)
[8]. A possible mechanism is that VSCs induce de-aggregation
of proteoglycans, which are elements of the extracellular
matrix of connective tissue, because sulfide cleaves disulfide
bonds [8]. The effect of VSCs on the permeability of lipopo-
lysaccharide (LPS) in tissues was studied. There was a large
variation in the ability of LPS to diffuse through the tissuesFigure 5 Percentage increase in permeability of oral mucosa
subjected for various periods of time to H2S or CH3SH [5]. (a)
15 ng H2S or CH3SH per ml 95% air/5% CO2, (b) 95% air/5% CO2.
Table 2 Effects of VSC on permeability of mucosa to PGE2 [8,9]
System %Change in permeability
Control a 7.7
CH3SH-treated
b +66.0
CH3SH/ZnCl2
c 2.5
a Mucosa was exposed to 95% air/5% CO2 atmosphere for 60 min.
b Mucosa was exposed for 60 min to 15 ng CH3SH/ml 95% air/5% CO2
atmosphere.
c Following 60 min to 15 ng CH3SH/ml 95% air/5% CO2 atmosphere,
mucosa was treated for 15 min with 0.22% ZnCl2 solution.
Table 1 Increase in diffusion of [14C]-LPS through mucosa
pretreated with CH3SH9
Average dpm of [14C]-LPS Diffused through mucosa
Unit 1 Unit 2
Test Control Test Control
392 111 653 341
Each value represents an average of three separate experiments.
Each unit originated from different sources. Test tissues were
exposed to 10 ng CH3SH/ml air/CO2 for 3 h. Then, they were over-
layed with 14C-LPS for 3 h.
Figure 6 Methyl mercaptan-induced suppression of collagen
synthesis by human gingival fibroblast cell cultures [16]. (a)
Results are derived from triplicate samples with approximately
150,000 dpm total in controls. Data indicate percent reduction in
radioactivity of CH3SH-exposed cultures when compared with
corresponding controls exposed to air/CO2. (b) All [
14C]-OH-Pro
activity was located within the cells during the 30 min pulse
period. The reduction, differences between test and control,
were analyzed by Student’s t-test, and significant differences at
p < 0.005 were found except the media of 30 min incubation
study.
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tissue sources.9) Taking this variation into account, the pre-
treatment of mucosa with CH3SH increased its permeability
to LPS 2—3-fold (Table 1) [9]. The CH3SH-exposed epithelial
surface of mucosa showed a markedly rough surface caused
by cell exfoliation and dissolution of the intercellular matrix
[9]. P. gingivalis, which has been implicated in the etiology of
periodontal disease, produces a large amount of CH3SH [10].
P. gingivalis also produces vesicles involving proteolytic
activities [9]. It has been demonstrated that CH3SH enhances
the activity of vesicles in digesting Type IV and Type I col-
lagen, as collagenase activity is thiol-dependent [9]. The
permeability of tissues to prostaglandin (PG) E2 increased by
66% after exposure to CH3SH (Table 2) [9]. It is suggested that
PGE2 that is diffused into the tissues may have a role in the
suppression of collagen synthesis, or may augment the pro-
duction of endotoxin-induced collagenase [9]. Accordingly,
an increment in the permeability of the sulcular tissues
induces damage to the epithelial barrier in the process of
periodontal disease.
Zinc ions are considered to be one of the most effective
deodorants for oral malodor. A zinc-containing mouthwash
reduces VSCs concentration by more than 90% for 3 h; zinc
inhibits cysteine proteinase activity, which plays a key role in
VSCs production [11]. Interestingly, the treatment of mucosa
with 0.22% zinc chloride nullified the effect of VSCs and
restored tissue permeability to its previous state (Table 2)
[9]. Zinc also inhibited the destruction of Type I collagen by
both CH3SH and P. gingivalis vesicles [9]. Hence, zinc ions
appear to act not only as a deodorant but also as a protective
agent for the maintenance of the permeability barrier.
6. Effects of VSCs on collagen synthesis and
degradation
VSCs have a detrimental effect on the integrity of collagen.
The H2S and CH3SH thiol groups combine with Type I collagen,
and H2S is incorporated directly into the peptide chains
[12,13]. Intermolecular cross-linkages of Type I acid-soluble
collagen are cleaved by VSCs, and it reverts to a more soluble
molecule [14,15]. It is concluded that exposure to CH3SH
causes an alteration in collagen metabolism. VSCs can mod-
ulate themetabolism of gingival fibroblasts. It has been found
that the protein content of CH3SH-exposed cell cultures was
decreased by approximately 25—35% [14,16]. This deleter-
ious effect was irreversible in test cultures subsequently
incubated in a VSCs-free environment [14]. DNA synthesisin gingival fibroblasts exposed to CH3SH was suppressed by
44.1% [14]. Further studies also indicated a reduction in
proline transport in the range of 40—50% in cultures exposed
to CH3SH [13,14]. The conversion of proline to hydroxyproline
was measured to assess the effect of CH3SH on the intra- and
extracellular metabolism of collagen in human gingival fibro-
blast cultures, utilizing the methods of Yaegaki et al. [17].
After a 30-min pulse, CH3SH had suppressed collagen synth-
esis by approximately 40% and increased the intracellular
degradation of newly synthesized collagen markedly (Figs. 6
and 7) [16]. An increase in the intracellular degradation of
collagen was observed in both 30-min and 12-h pulsed cul-
tures (Fig. 7) [16]. Extracellular degradation of collagen in
12-h pulsed cultures was also increased over 13-fold (Fig. 7)
[16]. The CH3SH-exposed cultures had a 70% reduction in
collagen, resulting from the combined effects of suppressed
synthesis and increased degradation [14]. CH3SH induced
reductions in both a1 and a2 chains of Type I collagen and
Figure 7 Increased intracellular and extracellular degradation
in CH3SH-exposed fibroblast cell cultures [16]. (a) Results are
derived from triplicate samples with approximately 150,000 dpm
total in controls. Data compare percent reduction in radioactiv-
ity of CH3SH-exposed cultures with corresponding controls
exposed to air/CO2. (b) All [
14C]-OH-Pro activity was shown to
be retained in the cells during the 30 min pulse period. Differ-
ences between test and control were analyzed by Student’s t-
test, and significant differences at p < 0.005 were found except
the media of 30 min incubation study.
Toxicities of oral malodorous compounds 105in Type III procollagen. It was suggested that mRNA synthesis
for Type III procollagen was suppressed in cultures exposed to
CH3SH because of probably decreased transcription of mRNA
[16].
Collagen loss in periodontally involved tissue causes per-
iodontal manifestations. Adverse effects of VSCs on collagen
metabolism of HGF may therefore have an important role in
periodontal etiology. VSCs concentration in mouth air
increases with the severity of the periodontal condition.
High concentrations of VSCs in mouth air were found in
periodontal subjects [64]. The CH3SH concentration or
CH3SH/H2S ratio is significantly higher in patients with per-
iodontal disease than in controls (Fig. 8) [4]. This is because
there is an elevated concentration of methionine in the
gingival sulcular fluid as well as a higher level of CH3SH
production by periodontal pathogens [64,65]. One would
therefore expect CH3SH rather than H2S to be more toxic
in a progressed pathological condition within the pocket.Figure 8 Periodontitis and CH3SH/H2S ratio in mouth air [6].
3 mm; n = 9, 4 mm; n = 6, 5 mm; n = 8, 6 mm; n = 8.7. Effects of VSCs on immunological
activities
The degenerative changes in periodontal tissue are attribu-
table to a combination of the presence ofmicroorganisms and
of the host’s immune factors [66]. In addition to the direct
effects of microorganisms, microbiota damage the host cells
indirectly by activating the host’s immune response. Matrix
metalloproteinases (MMPs) are involved in the progress of
periodontitis. One of the most characteristic changes
exerted by MMP is the degradation of Type I collagen, which
is the principal component of the extracellular matrix. This
destruction is due to increased levels of collagenases, whose
activities are increased through activation of the immune-
response system [66]. LPS stimulates mononuclear cells to
produce increased amounts of interleukin-1 (IL-1), which
induces the production of MMP. In periodontitis, IL-1 is found
at physiologically significant concentrations in gingival cre-
vicular fluid and in gingival tissue [67,68]. Moreover, the
production level of IL-1 in gingival crevicular fluid is corre-
lated with the severity of the disease [69]. Thus, higher
concentration of IL-1 increases the production of cAMP,
PGE2, collagenase and plasminogen activator; and PGE2
mediated with cAMP promotes bone resorption and stimu-
lates MMP activity (Fig. 9) [18,70,71].
Mononuclear cell cultures were stimulated with LPS in
the presence or absence of CH3SH, and the IL-1-dependent
cellular proliferation was determined. The supernatants
derived from cells exposed to CH3SH induced a twofold
higher stimulation index than supernatants of control cell
systems [18]. The amount of IL-1 increased more in the
presence of LPS and CH3SH than with LPS alone [18]. CH3SH
alone was also found to increase the production of IL-1 [18].
It has been shown that CH3SH stimulates PGE production by
gingival fibroblasts. The effect of CH3SH was scarcely
noticeable during initial exposure to CH3SH, but a longer
exposure significantly increased PGE production, both in
the presence and absence of IL-1 [18]. The effect of CH3SH
on cAMP production was also ascertained. CH3SH-supple-
mented cultures increased the amount of cAMP as well as
cultures supplemented with IL-1, LPS or IL-1/LPS. CH3SH
alone increased the production of collagenase. In combina-Figure 9 The relationship between IL-1 and periodontitis
[70,71].
106 K. Yaegakition with IL-1, LPS, or IL-1/LPS, CH3SH enhanced collage-
nase production significantly in compared with these com-
pounds alone. As cathepsin B requires thiol, it can be
speculated that CH3SH also enhances the activity of this
enzyme [18].
The above findings demonstrate that CH3SH is effective in
augmenting the LPS activation of IL-1 production by mono-
nuclear cells, and that CH3SH acts both directly and via IL-1
on HGF by enhancing the secretion of PGE, cAMP and col-
lagenase. It is also suggested that CH3SH plays a part in the
tissue destruction of periodontitis both by an indirect effect
through mononuclear cells and by a direct effect on fibro-
blasts as described above.
Leukocytes migrate into the periodontal pocket and pro-
duce active oxygen, which is very toxic to human gingival
tissues. The effect of active oxygen production in human
polymorphonuclear leukocytes has been determined by mea-
suring chemiluminescence [19]. With Fusobacterium stimula-
tion, production of active oxygen was dramatically increased
by the presence of CH3SH [19].
8. Effects of VSCs on the cytoskeleton and
cell migration
The cytoskeleton consists of microfilaments (actin microfila-
ments), microtubules and intermediate filaments. The cytos-
keleton regulates cell shape, mitosis, motility, integrity,
endocytosis and intracellular transport. The tight junctions
of cells allow compartments with different solute composi-
tion to be separate, and this controlled permeability of
intracellular space is important not only in preventing micro-
bial invasion but also in cell functions. The permeability is
controlled by both internal and extracellular factors, and one
of the most important internal factors is the cytoskeleton.
Actin filaments circumscribe the cell and fine filaments
extend into the tight junction [72]. Within the tight junction,
the actin filaments bind directly to the scaffolding proteins,
bonding to extracellular compounds through the membrane
[73].
The effects of CH3SH on the distribution of the cytoske-
leton have been investigated [20]. The cells exposed to
CH3SH were found to be rounder, less spread and less elon-
gated than unexposed cells. Actin microfilament bundles in
CH3SH-treated cells were found predominantly in the mar-
gins of the cell, as opposed to those in control cells that were
found in uniform distribution over the entire cell. Microtu-
bules in control cells were uniformly distributed, whereas
those in the CH3SH-treated cells were found only in the
central portion of the cell [20]. VSCs also inhibited the
migration of periodontal ligament cells, possibly due to these
changes in the cytoskeleton and also to the reduction in
fibronectin [22—25].
The signaling cascade is important in regulating the tight
junction barrier through the cytoskeleton. Actin microfila-
ments are regulated through Ras/Rho family GTPases [74].
Because Ras signal transduction is altered by VSCs, it has
been suggested that the effect of VSCs on the signal cascade
might lead to changes in cytoskeletons as described above
[74]. Furthermore, it has been reported that CH3SH lowers
the resting cytosolic pH, which may affect cell functions that
are associated with the cytoskeleton [23,74].9. Conclusion
It is suggested that VSCs are not only periodontal causative
agents but also affect general conditions. In periodontal
etiology, VSCs may play an important role in the initial stage
of the pathology.
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